Open repair was associated with increased incidence of acute renal dysfunction postoperatively. At long-term follow-up, the EVAR group had a significantly increased change in creatinine over the open group.
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Predictors of Survival in Malignant Aortic
Objective: Malignant aortic tumors are exceedingly rare. For that reason, no case series have been published so far in the literature, and a comprehensive review of clinical and therapeutic aspects is lacking. The aim of this study was to analyze all known cases of malignant aortic tumors and to identify predictors of patients' survival.
Methods: All patients with a diagnosis of aortic tumor treated in a single center together with all case reports and reviews available in the literature (through a specific PubMed search with keywords such as malignant and aorta or aortic tumor or sarcoma or angiosarcoma) were analyzed. Tumor primary location, clinical presentation, histologic features, and treatment choice were all examined. Survival at 1 year, 2 years, and 5 years and the possible preoperative and operative predictors of outcome were evaluated by Kaplan-Meier analysis with log-rank test.
Results: In addition to the 5 cases treated in our center, 218 other cases of malignant aortic tumor have been reported in the literature from 1873 to 2017. Overall, the mean age of the patients was 60.1 6 11.9 years, and the male to female ratio was 1.59:1. The mean overall survival from diagnosis was 13.6 6 7.7 months; 1-, 3-, and 5-year survival rates were 35.2% 6 3.7%, 10.9% 6 2.6%, and 6.1% 6 2.2%, respectively (Fig) . Chronic hypertension (P ¼ .03), fever (P ¼ .03), back pain (P ¼ .01), asthenia (P ¼ .04), and signs of peripheral embolization (P ¼ .007) were significant predictors of patients' poor outcome. Histologic subtypes had different impacts on survival with statistical significance (Table) . Compared with other treatment strategies, combined (surgical + medical) therapy had the best impact on the mean survival rate (surgical + medical, 32.5 6 8.2 months; medical, 14.2 6 7.6 months; surgical, 12 6 1.6 months; no treatment, 8.9 6 2.6 months; P ¼ .001). Analyzing an exclusively medical approach, chemotherapy had the best impact on mean survival rate (chemotherapy, 38.2 6 12.2 months; chemotherapy + radiotherapy, 27.6 6 10.6 months; radiotherapy, 20.4 6 6.5 months; and no medical treatment, 11.3 6 1.3 months; P ¼ .005).
Conclusions: Aortic tumors are a malignant pathologic condition with short survival after initial diagnosis. Survival is further diminished in the presence of clinical factors, such as hypertension, fever, back pain, asthenia, and peripheral embolization. Different histologic subtypes can be related to survival. Combined surgical and medical therapy, particularly chemotherapy, has shown the highest survival rate.
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Racial Disparities in Endovascular Repair of Thoracic Aortic Aneurysm and Dissection
Methods: The Vascular Quality Initiative data set was retrospectively queried to identify all patients who underwent TEVAR from 2010 to 2017. Univariate (c 2 test, t-test) and multivariate methods (logistic regression and Cox regression) were employed to study patient and operative characteristics in different racial groups and the effects of race on postoperative outcomes and long-term survival after TEVAR.
Results: A total of 9147 patients underwent TEVAR. Most of them were white (74.5%). Black patients were younger (61.4 6 15.0 vs 69.1 6 13.4) and more likely to be female (43.6% vs 34.2%; both P < .001; Table I ). Black patients were also more likely to be symptomatic (57% vs 32%) and to 
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